Maraviroc for Stroke Recovery (MASTER): protocol for a phase 2 double-blind placebo-controlled randomised clinical trial
Nicolas Broc, Gabriel Byczynski, Elisabeth Dirren, Emmanuel Carrera · 2026
Read Maraviroc for Stroke Recovery (MASTER): protocol for a phase 2 double-blind placebo-controlled randomised clinical trial by Nicolas Broc, Gabriel Byczynski, Elisabeth Dirren, Emmanuel Carrera (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13141164.txt.
Description
Nicolas Broc, Gabriel Byczynski, Elisabeth Dirren, and Emmanuel Carrera set out a 2026 trial protocol for a drug to aid stroke recovery. No drug yet helps patients regain function past the acute phase. The drug, maraviroc, blocks a receptor whose block freed brain rewiring in animal work.
Eighty patients with mid-level arm weakness will join within a week of their stroke. Half get the drug twice a day for ninety days and half a dummy pill, beside standard rehab. Arm function at day ninety is the main score, with brain scans of rewiring as a second check.
Catalog record
| CREATOR | Nicolas Broc, Gabriel Byczynski, Elisabeth Dirren, Emmanuel Carrera |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |